Just looking for some feedback from everyone. I was considering purchasing more Aurinia to possibly take advantage of the short term catalyst which would be the upcoming release of secondary data from their Phase IIb Aura trial to help recoup losses from the FDA debacle of RGLS. Maybe some have already done so. Anyone care to comment. Thanks fellas.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.